Ignite Creation Date:
2024-05-06 @ 9:37 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03023527
Status:
TERMINATED
Last Update Posted:
2018-05-23
First Post:
2017-01-11
Brief Title:
Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple Myeloma
Sponsor:
PETHEMA Foundation
Organization:
PETHEMA Foundation
Organization Data
Organization:
PETHEMA Foundation
Class:
OTHER
Study ID:
GEM-NIVOPOMDEX
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PETHEMA Foundation
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Adknoma Health Research SL | UNKNOWN |
| Celgene | INDUSTRY |
| Bristol-Myers Squibb | INDUSTRY |